Abstract:ABSTRACT The use of metagenomic next-generation sequencing technology to obtain complete viral genome sequences directly from clinical samples with low viral load remains challenging—especially in the case of respiratory viruses—due to the low copy number of viral versus host genomes. To overcome this limitation, target capture sequencing for the enrichment of specific genomes has been developed and applied for direct genome sequencing of viruses. However, as the efficiency of enrichment varies depending on the probes, the type of clinical sample, etc., validation is essential before target capture sequencing can be applied to clinical diagnostics. In this study, we evaluated the utility of target capture sequencing with a comprehensive viral probe panel for clinical respiratory specimens collected from patients diagnosed with SARS-CoV-2 or influenza type A. We focused on clinical specimens containing low copy numbers of viral genomes. Target capture sequencing yielded approximately 180- and 2,000-fold higher read counts of SARS-CoV-2 and influenza A virus, respectively, than metagenomic sequencing when the RNA extracted from specimens contained 59.3 copies/μL of SARS-CoV-2 or 625.1 copies/μL of influenza A virus. In addition, the target capture sequencing identified sequence reads in all SARS-CoV-2- or influenza type A-positive specimens with 70% of the full-length genomes of SARS-CoV-2 or influenza A virus. Furthermore, the target capture sequencing using comprehensive probes identified co-infections with viruses other than SARS-CoV-2, suggesting that this approach will not only detect a wide range of viruses but also contribute to epidemiological studies. IMPORTANCE Target capture sequencing has been developed and applied for direct genome sequencing of viruses in clinical specimens to overcome the low detection sensitivity of metagenomic next-generation sequencing. In this study, we evaluated the utility of target capture sequencing with a comprehensive viral probe panel for clinical respiratory specimens collected from patients diagnosed with SARS-CoV-2 or influenza type A, focusing on clinical specimens containing low copy numbers of viral genomes. Our results showed that the target capture sequencing yielded dramatically higher read counts than metagenomic sequencing for both viruses. Furthermore, the target capture sequencing using comprehensive probes identified co-infections with other viruses, suggesting that this approach will not only detect a wide range of viruses but also contribute to epidemiological studies.

Targeted Virome Sequencing Enhances Unbiased Detection and Genome Assembly of Known and Emerging Viruses—The Example of SARS-CoV-2

Unbiased metagenomic detection of RNA viruses for rapid identification of viral pathogens in clinical samples

Validation of an unbiased metagenomic detection assay for RNA viruses in viral transport media and plasma

Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

Direct genome sequencing of respiratory viruses from low viral load clinical specimens using target capture sequencing technology

Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights

Comprehensive viral enrichment enables sensitive respiratory virus genomic identification and analysis by next generation sequencing

Direct genome sequencing of respiratory viruses from low viral load clinical specimens using the target capture sequencing technology

Evaluation of the impact of concentration and extraction methods on the targeted sequencing of human viruses from wastewater

Broad-Range Virus Detection and Discovery Using Microfluidic PCR Coupled with High-throughput Sequencing

Comparison of the performance of two targeted metagenomic virus capture probe-based methods using reference control materials and clinical samples

Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing

Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants

Unveiling Inter- and Intra-Patient Sequence Variability with a Multi-Sample Coronavirus Target Enrichment Approach

Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression

vPro-MS enables identification of human-pathogenic viruses from patient samples by untargeted proteomics

Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern

ViralVectors: Compact and Scalable Alignment-free Virome Feature Generation

CAPTVRED: an automated pipeline for viral tracking and discovery from capture-based metagenomics samples

Evaluating metagenomics and targeted approaches for diagnosis and surveillance of viruses

Accurate viral genome reconstruction and host assignment with proximity-ligation sequencing